2016-09-22 13:54:47 UTC

AGA Perspectives Features Asymptomatic Pancreatic Cyst Debate

Sept. 22, 2016

The issue also provides quick takes on the growing role of GI in obesity treatment, big data in health care and the future of HCV therapy.

Check your inboxes. The new issue of AGA Perspectives is live online. The issue highlights a point/counterpoint discussion between James M. Scheiman, MD, AGAF, and Nuzhat A. Ahmad, MD, on the much debated topic of asymptomatic pancreatic cysts larger than 3 cm.

Dr. Scheiman argues for imagining surveillance, while Dr. Ahmad presents the case for EUS-FNA, and the debate touches on the AGA guideline on the same topic that was released in 2015.

The issue also provides quick takes on hot topics such as the growing role of GI in obesity treatment by Christopher C. Thompson, MD, MSC, FACG, FASGE, and an overview vedolizumab's role in IBD treatment and patient care by Edward V. Loftus Jr., MD, AGAF. Other articles touch on the role of big data in health care, the future of HCV therapy and more.

Read the full issue online at agaperspectives.org


More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.